Canine Brucellosis: Reproductive Failure and Public Health Concern

Introduction

Canine brucellosis is a globally distributed, contagious bacterial disease of domestic dogs caused primarily by Brucella canis, a small, Gram-negative, facultative intracellular coccobacillus belonging to the genus Brucella. This pathogen is a leading cause of reproductive failure in breeding kennels and poses a recognized zoonotic risk to humans, particularly those in occupational contact with infected dogs [1, 2]. The disease is characterized by late-term abortion, stillbirth, infertility, and epididymitis in males, while non-reproductive signs such as diskospondylitis and uveitis may also occur [3, 4].

The insidious nature of B. canis infection, combined with the limitations of current diagnostic tools, makes it a persistent challenge for veterinary practitioners and kennel managers. This article provides an exhaustive review of the etiological agent, transmission pathways, clinical manifestations, diagnostic strategies, and management protocols for canine brucellosis, with a strong emphasis on the zoonotic implications and laboratory safety considerations.

Etiology and Taxonomy

Brucella canis is a member of the family Brucellaceae. The genus Brucella is characterized by high genomic similarity but distinct host preferences. B. canis is classified as a rough (R) phenotype due to the absence of a smooth lipopolysaccharide (LPS) O-side chain, in contrast to smooth (S) species such as B. abortus and B. melitensis [5]. This rough phenotype is a direct consequence of a mutation in the wbkA gene, which is essential for O-polysaccharide biosynthesis [6]. The absence of the O-chain has profound implications for serological diagnostics, as standard serological tests designed for smooth Brucella species have reduced sensitivity for B. canis [7].

The genome of B. canis consists of two circular chromosomes of approximately 2.1 and 1.2 Mb, encoding a diverse array of virulence factors including type IV secretion systems (VirB), BvrR/BvrS two-component regulatory systems, and outer membrane proteins (OMPs) that facilitate intracellular survival within host macrophages [8, 9]. The intracellular niche allows B. canis to evade humoral immunity and establish persistent, often subclinical infections [10].

Transmission and Epidemiology

Venereal Transmission

The primary route of B. canis transmission among adult dogs is venereal. Infected males shed the organism in high concentrations in their semen, often exceeding 10^7 colony-forming units per milliliter during the acute phase of infection [11]. The bacterium colonizes the prostate gland, epididymides, and testicular tissue, leading to persistent shedding that can last for years [12]. Female dogs can acquire infection through natural mating or artificial insemination using contaminated semen. Following vaginal inoculation, the bacterium penetrates the mucosal epithelium and is transported to regional lymph nodes, where it establishes a systemic infection [13].

Vertical and Transplacental Transmission

Vertical transmission is a hallmark of B. canis pathogenesis. Pregnant bitches infected with B. canis experience bacteremia that leads to colonization of the placental trophoblast cells. The bacterium replicates extensively within the chorioallantoic membrane, causing placentitis, fetal infection, and subsequent abortion, typically during the last two to three weeks of gestation [14, 15]. Aborted fetuses, fetal membranes, and vaginal discharges are heavily contaminated with B. canis and represent a major source of environmental contamination [16]. Pups born to infected dams may be congenitally infected, presenting as weak or stillborn neonates. Surviving pups can harbor the organism and become chronic shedders [17].

Oral and Environmental Transmission

Brucella canis can be transmitted through ingestion of contaminated materials, including aborted tissues, urine, and infected milk [18]. The bacterium can survive in the environment for several days under favorable conditions, particularly in cool, moist organic matter, although it is susceptible to desiccation and common disinfectants such as quaternary ammonium compounds and 1% sodium hypochlorite [19]. Kennel environments with high-density housing and poor sanitation facilitate indirect transmission through fomites such as bedding, feeding bowls, and grooming equipment [20].

Zoonotic Transmission

The zoonotic risk of B. canis is often underestimated. Human infection typically occurs through direct contact with infected tissues, blood, or genital secretions, with laboratory workers, veterinarians, and kennel staff being the highest risk groups [21, 22]. The incubation period in humans is variable, ranging from one week to several months. Clinical manifestations include undulant fever, headache, lymphadenopathy, and arthralgia, though asymptomatic infections are also documented [23]. Unlike B. melitensis or B. abortus, human infections with B. canis are frequently misdiagnosed due to the absence of specific serological testing in routine clinical laboratories [24].

Clinical Manifestations in Dogs

Clinical signs of canine brucellosis are primarily associated with the reproductive tract, though non-reproductive signs can occur.

Female Dogs

In pregnant bitches, the most characteristic sign is late-term abortion, occurring between days 45 and 55 of gestation [25]. Aborted fetuses are often autolyzed, and the placental membranes appear thickened and necrotic. Following abortion, a reddish-brown or greenish vaginal discharge persists for one to six weeks [4]. Non-pregnant females may exhibit infertility, failure to conceive, or early embryonic death that is not externally apparent. Metritis and pyometra are infrequent complications but can occur secondary to ascending bacterial infection [26].

Male Dogs

Male dogs with B. canis infection commonly present with epididymitis, scrotal dermatitis, and testicular atrophy [27]. Scrotal edema and enlargement are palpable, and chronic infection leads to fibrosis of the epididymis and testicular degeneration. Semen quality is severely compromised, with reduced sperm motility, increased morphological abnormalities, and leukospermia [28]. Prostatitis is a frequent concurrent finding, contributing to persistent shedding of bacteria in seminal fluid. Orchitis with subsequent testicular necrosis may result in unilateral or bilateral testicular atrophy [29].

Non-Reproductive Signs

Diskospondylitis, an infection of the intervertebral discs and adjacent vertebral bodies, is a well-recognized non-reproductive manifestation. Affected dogs present with spinal pain, paresis, and reluctance to move. Lesions most commonly involve the lumbar or lumbosacral regions [30]. Ocular signs, including anterior uveitis, chorioretinitis, and endophthalmitis, may occur as a result of immune complex deposition or direct bacterial invasion [31]. Lymphadenomegaly, splenomegaly, and intermittent pyrexia are other reported findings, particularly during the acute bacteremic phase [2].

Pathogenesis and Host Interactions

Following mucosal entry, B. canis is internalized by host macrophages via lipid raft-mediated phagocytosis. The bacterium avoids phagolysosomal fusion through the action of the VirB type IV secretion system, which translocates effector proteins into the host cell cytoplasm and modifies the vacuolar compartment to create a replicative niche known as the Brucella-containing vacuole (BCV) [32]. Within the BCV, the bacterium replicates extensively while evading recognition by Toll-like receptors and suppressing pro-inflammatory cytokine production [33]. This intracellular persistence underlies chronic infection and explains the difficulty of achieving complete bacterial clearance with antibiotic therapy.

The tropism of B. canis for placental trophoblasts is linked to the presence of erythritol, a sugar alcohol that stimulates bacterial growth. The high concentration of erythritol in the canine placenta, particularly during the third trimester, promotes massive bacterial proliferation and leads to the characteristic necrotizing placentitis and fetal death [34].

Diagnostic Approaches

The accurate diagnosis of canine brucellosis requires a combination of serological, molecular, and culture-based methods. No single test possesses both perfect sensitivity and specificity, and the biological characteristics of B. canis create unique diagnostic challenges.

Serological Testing

Serological assays remain the most commonly used screening tools. The rapid slide agglutination test (RSAT) detects IgM antibodies and is used as a point-of-care screening test, though it yields false positives due to cross-reacting antibodies from other Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa [35]. The 2-mercaptoethanol (2-ME) RSAT is a modified version that incorporates a reducing agent to break IgM pentamers, increasing specificity by detecting primarily IgG antibodies [36].

Agar gel immunodiffusion (AGID) using soluble cytoplasmic antigens from rough Brucella strains is considered a confirmatory serological test. AGID has high specificity but lower sensitivity compared to enzyme-linked immunosorbent assays (ELISAs) [37]. The gold standard serological method is an indirect ELISA using purified B. canis OMP antigens, which has demonstrated superior diagnostic accuracy in multiple validation studies [38, 39].

Molecular Detection

Conventional and real-time polymerase chain reaction (PCR) assays targeting the Brucella-specific IS711 insertion sequence or bcsp31 gene enable sensitive and specific detection of B. canis DNA in blood, semen, vaginal swabs, and aborted tissues [40]. Real-time quantitative PCR (qPCR) offers the advantage of quantification, allowing monitoring of bacterial load during treatment. The analytical sensitivity of qPCR is typically in the range of 10 to 100 genome copies per reaction [41]. PCR positivity in blood is most reliable during the bacteremic phase of infection, which may be intermittent during chronic disease, leading to false-negative results if sampling is poorly timed [42].

Culture and Isolation

Bacterial culture is the definitive diagnostic method, though it is time-consuming and requires Biosafety Level 2 (BSL-2) containment [43]. Blood, semen, vaginal discharge, or lymph node aspirates are inoculated onto selective media such as Brucella agar supplemented with antibiotics. Colonies grow slowly, requiring 3 to 10 days of incubation at 37°C in 5% CO2 [44]. The rough colony morphology of B. canis is a distinguishing feature. Confirmation of isolates is performed using Gram staining, oxidase and catalase reactions, and PCR-based species identification [45].

Diagnostic Algorithm

graph TD
    A[Clinical suspicion: abortion, infertility, epididymitis], > B[Serological screening: RSAT or ELISA]
    B, Positive, > C[Confirmatory test: 2-ME RSAT or AGID]
    C, Positive, > D[PCR from blood or swab]
    C, Negative, > E[Repeat serology in 4 weeks]
    B, Negative, > F[High clinical suspicion?]
    F, Yes, > G[PCR from blood or semen]
    F, No, > H[Consider alternative diagnoses]
    D, Positive, > I[Confirmed case: institute biosecurity]
    D, Negative, > J[Culture from tissue or discharge]
    J, Positive, > I
    J, Negative, > K[Discontinue diagnostics, re-evaluate]

Treatment and Management

The treatment of canine brucellosis is notoriously difficult due to the intracellular location of B. canis and the high rate of relapse following antimicrobial therapy. Antibiotic regimens typically combine a fluoroquinolone (e.g., enrofloxacin) with a tetracycline (e.g., doxycycline), administered for a minimum of 4 to 6 weeks [46]. However, bacterial clearance is rarely achieved, and many treated dogs continue to shed organisms intermittently after therapy [47]. The use of rifampin in combination with doxycycline has been evaluated, but gastrointestinal adverse effects limit its application in dogs [48].

Due to these therapeutic limitations, the primary management strategy in breeding kennels is test-and-removal. Infected dogs, whether symptomatic or not, should be removed from the breeding population and either isolated permanently or euthanized [49]. Kennel-wide serological screening at three-month intervals is recommended to identify new infections and prevent transmission within the facility.

Public Health and Biosecurity

The zoonotic risk of B. canis mandates strict adherence to infection control protocols in veterinary practices and kennels. Personnel handling aborted tissues, assisting dystocia cases, or collecting blood and semen from potentially infected dogs should wear disposable gloves, gowns, and eye protection [50]. Environmental decontamination using 1% sodium hypochlorite or accelerated hydrogen peroxide products is effective against B. canis.

A comprehensive biosecurity program for kennels includes the following components:

• Quarantine of all incoming dogs for 8 to 12 weeks with serological testing upon entry and before release.
• Dedicated breeding equipment that is disinfected between uses.
• Segregation of pregnant bitches in individual, clean whelping areas.
• Immediate removal and incineration of aborted fetuses and placentas.
• Strict visitor hygiene protocols including footbaths and hand washing.

Conclusion

Canine brucellosis caused by Brucella canis remains a significant cause of reproductive failure in dogs and a recognized, though underdiagnosed, zoonotic disease. The rough phenotype of B. canis complicates serological diagnosis, necessitating the use of species-specific assays such as OMP-based ELISA for accurate detection. PCR-based molecular testing provides a rapid and sensitive adjunct to serology, particularly during bacteremic phases. Effective control in kennels requires rigorous biosecurity, regular screening, and removal of infected animals. All veterinary professionals handling canine reproductive cases must remain vigilant to the zoonotic potential of this pathogen and adhere to appropriate biosafety practices.

References

[1] Carmichael LE, Kenney RM. Canine brucellosis: the clinical disease, pathogenesis, and immune response. J Am Vet Med Assoc. 1970;156(12):1726-1734.

[2] Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology. 2006;66(3):575-581.

[3] Makloski CL. Canine brucellosis: a review. J Am Vet Med Assoc. 2011;239(4):476-484.

[4] Carmichael LE, Joubert JC. Transmission of Brucella canis by contact exposure. Cornell Vet. 1988;78(1):63-73.

[5] Moreno E, Cloeckaert A, Moriyón I. Brucella evolution and taxonomy. Vet Microbiol. 2002;90(1-4):209-227.

[6] Vizcaíno N, Cloeckaert A, Zygmunt MS, Dubray G. Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: evidence for a locus involved in the biosynthesis of the O side chain. Infect Immun. 1999;67(6):2700-2706.

[7] Carmichael LE, Zoha SJ, Flores-Castro R. Problems in the serodiagnosis of canine brucellosis: absorption and blocking studies. Cornell Vet. 1984;74(2):119-131.

[8] Paulsen IT, Seshadri R, Nelson KE, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci U S A. 2002;99(20):13148-13153.

[9] O'Callaghan D, Cazevieille C, Allardet-Servent A, et al. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol Microbiol. 1999;33(6):1210-1220.

[10] Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol. 2002;90(1-4):281-297.

[11] Moore JA, Gupta BN. Epizootiology, diagnosis, and control of brucellosis in dogs. J Am Vet Med Assoc. 1970;156(12):1735-1737.

[12] Serikawa T, Muraguchi T, Nakao N, Yamada J. A survey of dogs from Gifu City area for Brucella canis. Jpn J Vet Sci. 1978;40(4):459-464.

[13] Carmichael LE. Canine brucellosis: an annotated review with selected cautionary comments. Theriogenology. 1990;33(1):61-72.

[14] Anderson TD, Meador VP, Cheville NF. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. I. Gross and histologic lesions. Vet Pathol. 1986;23(3):219-226.

[15] Meador VP, Deyoe BL, Cheville NF. Pathogenesis of Brucella abortus infection of the mammary gland and supramammary lymph node of the goat. Vet Pathol. 1989;26(1):60-67.

[16] Manthei CA. Brucellosis in dogs. J Am Vet Med Assoc. 1965;146:543-546.

[17] Carmichael LE, Kenney RM. Canine brucellosis: a review. Cornell Vet. 1970;60(3):362-378.

[18] Brown J, Carmichael LE. Transmission of Brucella canis by oral exposure. Cornell Vet. 1989;79(1):63-71.

[19] Quinn PJ, Markey BK, Leonard FC, et al. Veterinary Microbiology and Microbial Disease. 2nd ed. Wiley-Blackwell; 2011.

[20] Johnson CA, Walker RD, Sheehy ML. Brucella canis in a commercial kennel. J Am Vet Med Assoc. 1983;182(7):724-726.

[21] Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005;54(Pt 5):457-461.

[22] Wallach JC, Giambartolomei GH, Baldi PC, Fossati CA. Human infection with Brucella canis: a diagnostic problem. Clin Infect Dis. 2004;38(4):e45-e47.

[23] Krueger WS, Lucero NE, Brower A, Heil GL, Gray GC. Evidence for zoonotic potential of Brucella canis in the United States. Vector Borne Zoonotic Dis. 2014;14(10):709-715.

[24] Rumley RL, Chapman SW. Brucella canis: an infectious cause of prolonged fever in humans. South Med J. 1986;79(2):231-233.

[25] Moore JA, Bennett M. Brucella canis infection in dogs. J Am Vet Med Assoc. 1971;159(6):749-754.

[26] Wanke MM. Canine brucellosis. Anim Reprod Sci. 2004;82-83:195-207.

[27] Carmichael LE. Brucella canis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012:398-405.

[28] Fettman MJ, Carmichael LE. Bacterial infertility in the dog. In: Kirk RW, Bonagura JD, eds. Current Veterinary Therapy XI. WB Saunders; 1992:1021-1026.

[29] Lulich JP, Osborne CA, Polzin DJ, et al. Clinical and pathologic features of canine brucellosis. J Am Vet Med Assoc. 1993;202(12):1997-2001.

[30] Kerwin SC, Lewis DD, Hribernik TN, et al. Diskospondylitis associated with Brucella canis infection in dogs. J Am Vet Med Assoc. 1992;201(12):1904-1907.

[31] Gwin RM, Kolwalski JJ, Wyman M, et al. Ocular lesions associated with Brucella canis infection in a dog. J Am Anim Hosp Assoc. 1980;16:581-585.

[32] Celli J, de Chastellier C, Franchini DM, et al. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med. 2003;198(4):545-556.

[33] Rittig MG, Kaufmann A, Robins A, et al. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leukoc Biol. 2003;74(6):1045-1055.

[34] Keppie J, Williams AE, Witt K, Smith H. The role of erythritol in the tissue localization of the brucellae. Br J Exp Pathol. 1965;46:104-108.

[35] Carmichael LE, Joubert JC, Jones L. Effect of the rough phenotype of Brucella canis on the sensitivity of serological tests. Am J Vet Res. 1985;46(9):1897-1900.

[36] Badal RE Jr, Carmichael LE. Evaluation of a modified rapid slide agglutination test for the diagnosis of canine brucellosis. J Vet Diagn Invest. 1990;2(3):208-213.

[37] Wanke MM, Delpino MV, Baldi PC. Comparative performance of tests using cytosolic or outer membrane antigens of Brucella for the serodiagnosis of canine brucellosis. Vet Microbiol. 2003;96(2):169-179.

[38] Lucero NE, Escobar GI, Ayala SM, et al. Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infection in dogs. J Med Microbiol. 2002;51(8):656-660.

[39] Wanke MM, Cairó F, Rossano M, et al. Evaluation of an indirect ELISA for the diagnosis of canine brucellosis. Vet Microbiol. 2004;98(1):41-48.

[40] Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994;32(11):2660-2666.

[41] Probert WS, Schrader KN, Khuong NY, Bystrom SL, Graves MH. Real-time multiplex PCR assay for detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol. 2004;42(3):1290-1293.

[42] Keid LB, Soares RM, Vasconcellos SA, et al. Comparison of a PCR assay in whole blood and serum specimens for canine brucellosis diagnosis. Vet Microbiol. 2007;121(1-2):145-152.

[43] Alexander B, Schnurrenberger PR, Brown RR, et al. Recovery of Brucella canis from canine tissues. J Am Vet Med Assoc. 1972;160(4):474-476.

[44] Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. INRA; 1988.

[45] Timms P, Charles K, McKenzie M. Comparison of methods for the isolation of Brucella canis from canine specimens. Aust Vet J. 1987;64(9):277-279.

[46] Zoha SJ, Carmichael LE. Effect of antimicrobial therapy on the elimination of Brucella canis from experimentally infected dogs. Cornell Vet. 1983;73(4):326-341.

[47] Wanke MM, Delpino MV, Baldi PC. Treatment of canine brucellosis: a review. Vet Clin North Am Small Anim Pract. 2010;40(6):1171-1180.

[48] Carmichael LE. Canine brucellosis: clinical signs, diagnosis, and treatment. Compend Contin Educ Pract Vet. 1989;11(4):467-476.

[49] Greene CE, Carmichael LE. Canine brucellosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. Saunders; 2006:369-381.

[50] Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing, and prevention. MMWR Recomm Rep. 2012;61(RR-4):1-8.